Esophagectomy after definitive chemoradiation in esophageal cancer: a safe therapeutic strategy
Diseases of the Esophagus · 2024
DOI: 10.1093/dote/doae059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases of the Esophagus, 2024. Verfasst von Eline G M van Geffen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Esophagectomy, Esophageal Neoplasms, Neoadjuvant Therapy, Anastomotic Leak. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The standard treatment regimen for esophageal cancer is chemoradiation followed by esophagectomy. However, the use of neoadjuvant chemoradiotherapy damages the surrounding tissue, which potentially increases the risk of postoperative complications, including anastomotic leakage. The impact of definitive chemoradiotherapy (dCRT, 50.4 Gy radiotherapy) compared to the standard neoadjuvant scheme (nCRT, 41.4 Gy radiotherapy) prior to surgery on the incidence of anastomotic leakage remains poorly understood. To study this, all patients who received dCRT between 2011 and 2021 followed by esophagectomy were included. For each patient, two patients who received nCRT were selected as matched controls. Outcomes included postoperative anastomotic leakage, pulmonary and other complications, anastomotic stenosis, pulmonary and other postoperative complications (Clavien Dindo Classification ≥1), and overall survival. One hundred and eight patients were included with a median follow-up of 28 months. The time between neoadjuvant treatment and surgery was longer in the dCRT group compared to the nCRT group (65 vs. 48 days, P < 0.001). Postoperatively, significantly more patients in the dCRT group suffered from anastomotic leakage (11% vs. 1%, P = 0.04) and anastomotic stenosis (42% vs. 17%, P < 0.01). No differences were found for other complications or overall survival between both groups. In conclusion, preoperative dCRT is associated with a higher risk of anastomotic leakage and stenosis. These complications, however, can be treated effectively. Therefore, esophagectomy after dCRT is considered to be an appropriate treatment strategy in a selected patient group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Gastroenterology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
ORCID-Profile: Eline G M van Geffen
Zitieren
APA
van Geffen, E. G. M., Neelis, K. J., Putter, H., Slingerland, M., de Steur, W. O., van der Kraan, J., van der Molen, A. J., Crobach, A. S. L. P., & Hartgrink, H. H. (2024). Esophagectomy after definitive chemoradiation in esophageal cancer: a safe therapeutic strategy. Diseases of the Esophagus. https://doi.org/10.1093/dote/doae059
Vancouver
van Geffen EGM, Neelis KJ, Putter H, Slingerland M, de Steur WO, van der Kraan J, et al. Esophagectomy after definitive chemoradiation in esophageal cancer: a safe therapeutic strategy. Diseases of the Esophagus. 2024. doi:10.1093/dote/doae059
BibTeX
@article{vanGeffen2024,
author = {van Geffen, Eline G M and Neelis, Karen J and Putter, Hein and Slingerland, Marije and de Steur, Wobbe O and van der Kraan, Jolein and van der Molen, Aart J and Crobach, A Stijn L P and Hartgrink, Henk H},
title = {Esophagectomy after definitive chemoradiation in esophageal cancer: a safe therapeutic strategy},
journal = {Diseases of the Esophagus},
year = {2024},
doi = {10.1093/dote/doae059}
}
EUVIMED